#ALKPositive

LuciusPharma: Advancing ALK-Positive Lung Cancer Treatment with Crizotinib LuciusPharma is committed to advancing care for ALK-positive lung cancer patients with Crizotinib, a targeted therapy designed to improve treatment outcomes. Visit Now: https://luciuspharma.com/medicineList?relationDepartment=CoreProducts #LuciusPharma #Crizotinib #ALKPositive #LungCancerCare #TargetedTherapy

Crizalk 250mg contains the active substance Crizotinib. It is an antineoplastic medicine that belongs to the class of tyrosine kinase inhibitors. This medicine is prescribed to treat patients with a type of lung cancer called Anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) that is locally advanced or metastatic. #mrmed #mrmedpharmacy #alkpositive #lungcancer #nsclc #crizalkcapsule Know more: https://www.mrmed.in/medicines/crizalk-250mg-capsule